Kim A Sol, Youn Chang Ho, Ko Hae Jin, Kim Hyo Min
J Palliat Care. 2014 Spring;30(1):24-31.
By examining clinical parameters associated with survival time and analyzing patients' survival times using prognostic scores, this study aimed to provide helpful information related to the treatment of terminal cancer patients.
We retrospectively reviewed the medical records of 415 inpatients who died in the hospices of two hospitals from March 2009 to August 2011 then analyzed differences in survival times and relative risk for clinical parameters and prognostic scores.
There were 15 parameters associated with survival time. Performance decline was the most influential factor. The optimal scores for predicting four-week survival were over 4.5 on the Palliative Prognostic Index (PPI), over 10 on the Palliative Prognostic (PaP) Score, and 30 or under on the Palliative Performance Scale (PPS).
Performance decline is a major factor affecting survival time. The PaP is the most useful tool for predicting four-week survival, with an optimal value of over 10.
通过检查与生存时间相关的临床参数,并使用预后评分分析患者的生存时间,本研究旨在提供与晚期癌症患者治疗相关的有用信息。
我们回顾性分析了2009年3月至2011年8月在两家医院临终关怀病房死亡的415例住院患者的病历,然后分析了生存时间的差异以及临床参数和预后评分的相对风险。
有15个参数与生存时间相关。功能状态下降是最具影响力的因素。预测四周生存的最佳评分是姑息预后指数(PPI)超过4.5、姑息预后(PaP)评分超过10以及姑息功能状态量表(PPS)为30或更低。
功能状态下降是影响生存时间的主要因素。PaP是预测四周生存最有用的工具,最佳值超过10。